HARRINGTONINE IN TREATMENT OF POLYCYTHEMIA VERA

被引：0

作者：

Lu Lian-huang

Lin Shu-ping

Liang Yu-ying

Song Tuan-yue

Li Li-ying

机构：

[1] DepartmentofMedicine

[2] FujianProvincialPeople'sHospital

[3] FujianProvincialHematologicResearchLaboratory

[4] MedicineDepartment

[5] FujianProvincialHospital

来源：

CHINESE MEDICAL JOURNAL | 1983年 / 07期

关键词：

D O I：

暂无

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

12 polycythemia vera (PV) patients treated with iv drip harringtonine in 14 treatment courses all achieved complete remissions (CR) in a median 60 days. 4 relapsed, 2 of these retreated with harringtonine alone again achieved CR. The harringtonine median total dose is 98 mg. Follow up shows that harringtonine is a safe reliable new PV therapy, comparing favorably with the other PV treatments. It has not caused acute leukemia sequelae as some other anti-PV drugs.

引用

页码：535 / 535